Literature DB >> 33218600

Clinical Implementation of Total-Body PET/CT at University of California, Davis.

Lorenzo Nardo1, Yasser G Abdelhafez2, Benjamin A Spencer2, Ramsey D Badawi3.   

Abstract

This work outlines the clinical implementation of total-body PET/CT from the time of installation at UC Davis EXPLORER Molecular Imaging Center in May 2019 to date (September 2020). This process has not been without challenges: logistical, technical, and medical problems were all encountered and are discussed. The mutual learning/teaching engagement among nuclear medicine technologists, research staff, radiologists, and referring physicians has been the key to the past year's achievements; these include development of ground-breaking clinical protocols for a range of Food and Drug Administration-approved radiotracers, and the attainment of a measure of expertise in clinical total-body PET/CT.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Human imaging; Positron emission tomography; Total-body PET

Mesh：

Substances：

Year:  2021        PMID： 33218600      PMCID： PMC8447866          DOI： 10.1016/j.cpet.2020.09.006

Source DB:  PubMed          Journal:  PET Clin        ISSN： 1556-8598


  7 in total

1.  Positron range in PET imaging: an alternative approach for assessing and correcting the blurring.

Authors:  L Jødal; C Le Loirec; C Champion
Journal:  Phys Med Biol       Date:  2012-05-30       Impact factor: 3.609

2.  Unsuspected pulmonary embolism on CT scanning: yet another headache for clinicians?

Authors:  Sujal R Desai
Journal:  Thorax       Date:  2007-06       Impact factor: 9.139

3.  First Human Imaging Studies with the EXPLORER Total-Body PET Scanner.

Authors:  Ramsey D Badawi; Hongcheng Shi; Pengcheng Hu; Shuguang Chen; Tianyi Xu; Patricia M Price; Yu Ding; Benjamin A Spencer; Lorenzo Nardo; Weiping Liu; Jun Bao; Terry Jones; Hongdi Li; Simon R Cherry
Journal:  J Nucl Med       Date:  2019-02-07       Impact factor: 10.057

4.  FDG-PET maximum standardised uptake value is associated with variation in survival: analysis of 498 lung cancer patients.

Authors:  Andrew Davies; Carol Tan; Christos Paschalides; Sally F Barrington; Mike O'Doherty; Martin Utley; Tom Treasure
Journal:  Lung Cancer       Date:  2006-11-03       Impact factor: 5.705

5.  Reproducibility of standardized uptake value measurements determined by 18F-FDG PET in malignant tumors.

Authors:  Claude Nahmias; Lindi M Wahl
Journal:  J Nucl Med       Date:  2008-10-16       Impact factor: 10.057

6.  Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence.

Authors:  Jeremie Calais; Wolfgang P Fendler; Ken Herrmann; Matthias Eiber; Francesco Ceci
Journal:  J Nucl Med       Date:  2017-12-14       Impact factor: 10.057

7.  Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

Authors:  Michel Meignan; Andrea Gallamini; Michel Meignan; Andrea Gallamini; Corinne Haioun
Journal:  Leuk Lymphoma       Date:  2009-08
  7 in total
  3 in total

1.  Relating18F-FDG image signal-to-noise ratio to time-of-flight noise-equivalent count rate in total-body PET using the uEXPLORER scanner.

Authors:  Edwin K Leung; Yasser G Abdelhafez; Eric Berg; Zhaoheng Xie; Xuezhu Zhang; Reimund Bayerlein; Benjamin Spencer; Elizabeth Li; Negar Omidvari; Aaron Selfridge; Simon R Cherry; Jinyi Qi; Ramsey D Badawi
Journal:  Phys Med Biol       Date:  2022-06-10       Impact factor: 4.174

Review 2.  Total-body PET/CT - First Clinical Experiences and Future Perspectives.

Authors:  Quinn Kwan-Tai Ng; Elizabeth Katherine Anna Triumbari; Negar Omidvari; Simon R Cherry; Ramsey D Badawi; Lorenzo Nardo
Journal:  Semin Nucl Med       Date:  2022-03-07       Impact factor: 4.802

Review 3.  Advantages and Applications of Total-Body PET Scanning.

Authors:  Sanaz Katal; Liesl S Eibschutz; Babak Saboury; Ali Gholamrezanezhad; Abass Alavi
Journal:  Diagnostics (Basel)       Date:  2022-02-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.